Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes
about
Antihypertensive agents for preventing diabetic kidney diseaseUrinary Markers of Tubular Injury in Early Diabetic NephropathyProteomics for prediction of disease progression and response to therapy in diabetic kidney diseaseNon-Proteinuric Diabetic NephropathyAssessing the Validity of Surrogate Outcomes for ESRD: A Meta-AnalysisAntihypertensive treatment and renal protection: the role of drugs inhibiting the renin-angiotensin-aldosterone systemMonitoring kidney function and albuminuria in patients with diabetes.Diabetes, Kidney Disease, and Cardiovascular Outcomes in the Jackson Heart StudyThe burden of nephrotoxic drug prescriptions in patients with chronic kidney disease: a retrospective population-based study in Southern ItalyDiabetic nephropathy - Epidemiology in Asia and the current state of treatmentTherapeutic management of diabetic kidney disease.Clinical therapeutic strategies for early stage of diabetic kidney disease.Study Protocol--accurate assessment of kidney function in Indigenous Australians: aims and methods of the eGFR studyDistribution of cardiovascular disease and retinopathy in patients with type 2 diabetes according to different classification systems for chronic kidney disease: a cross-sectional analysis of the renal insufficiency and cardiovascular events (RIACE)Proteinuria and reduced glomerular filtration rate as risk factors for acute kidney injury.Association between urinary angiotensinogen levels and renal and cardiovascular prognoses in patients with type 2 diabetes mellitus.Obesity as an effect modifier of the association between leptin and diabetic kidney disease.Cardiovascular complications of diabetic kidney disease.Potential Role of Serum and Urinary Biomarkers in Diagnosis and Prognosis of Diabetic Nephropathy.Dyslipidemia, kidney disease, and cardiovascular disease in diabetic patients.Rationale, design, and baseline characteristics of a randomized, placebo-controlled cardiovascular outcome trial of empagliflozin (EMPA-REG OUTCOME™)Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers and combined therapy in patients with micro- and macroalbuminuria and other cardiovascular risk factors: a systematic review of randomized controlled trials.Association between CNDP1 genotype and diabetic nephropathy is sex specific.The estimated GFR, but not the stage of diabetic nephropathy graded by the urinary albumin excretion, is associated with the carotid intima-media thickness in patients with type 2 diabetes mellitus: a cross-sectional studyKidney function and the risk of cardiovascular disease in patients with type 2 diabetes.Comparison of different measures of urinary protein excretion for prediction of renal events.Development of contrast-induced acute kidney injury after elective contrast media exposure in patients with type 2 diabetes mellitus: effect of albuminuria.Albuminuria is associated with left ventricular hypertrophy in patients with early diabetic kidney diseaseDiabetic kidney disease: from epidemiology to clinical perspectives.Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart Association and American Diabetes Association.Impact of chronic kidney disease on the prevalence of cardiovascular disease in patients with type 2 diabetes in Spain: PERCEDIME2 studyImpact of age and overt proteinuria on outcomes of stage 3 to 5 chronic kidney disease in a referred cohort.Association of high blood pressure with renal insufficiency: role of albuminuria, from NHANES, 1999-2006.Osteoprotegerin and mortality in type 2 diabetic patientsChronic kidney disease in the type 2 diabetic patients: prevalence and associated variables in a random sample of 2642 patients of a Mediterranean area.Urine and plasma metabolites predict the development of diabetic nephropathy in individuals with Type 2 diabetes mellitus.End organ damage in hypertension.Albuminuria and estimated glomerular filtration rate independently associate with acute kidney injury.Comparison of estimated glomerular filtration rates and albuminuria in predicting risk of coronary heart disease in a population with high prevalence of diabetes mellitus and renal diseaseClinical value of NGAL, L-FABP and albuminuria in predicting GFR decline in type 2 diabetes mellitus patients.
P2860
Q24202090-DB881D79-419C-4AF3-BF08-38BE3E66E89CQ26746921-7F244AF3-94CA-4683-A593-3262F677C9A6Q26747131-BEF16C47-C70A-486C-B614-B5A71F24AEB4Q26786923-2CFEA81B-4AC0-44A3-B2D4-94301D809146Q26863404-A5DC6D8F-9119-43F8-9049-16F87A3E703BQ26865691-91391222-4188-4C3B-AB73-2EDF6D75C5A7Q27691297-2A591107-F7A4-458F-8DCF-41A98772497BQ28385891-DCFD9EDF-96D8-4417-AADD-EC0C25D674E3Q28539876-5A162DFD-B656-46D0-8641-CA3D9C6FD865Q28742785-9D6C5FEB-9282-4EAF-9305-7BC904E9079DQ30362729-C3B2B124-8A35-4F14-9B9A-5C2F2A749B5FQ30363683-0A4BE79B-BB34-44DF-A9D6-ED0698EC8C46Q33532317-A6055125-29EF-4884-A415-D05F5063F9B6Q33558940-E02509CA-FC7F-43E6-95D5-7E3B9BA1760DQ33560648-920B036C-6E57-46A7-953F-960CD9157DBAQ33585798-9F21DCA8-6277-4847-A9DC-629F3F5EBBB3Q33622272-0FFF0F76-B423-4DFB-AE0E-EBA880FF1F97Q33711038-B3C71B5F-8733-4FCD-8F7E-856F4D53FBFCQ33772238-F9695089-E2D9-4AA3-A9A1-44A341CB3290Q33776181-453D198F-8EAF-43C1-93D8-3C6C792B34EBQ33812170-CCC77002-AFA6-48A9-9191-263956855B81Q33836604-88E91C8F-5983-4878-82CD-DD4697EDDD17Q33869853-11C09340-8BD4-44FE-AC85-01AB080D6DBAQ33881733-07D86833-DBC6-46F1-ADFD-5FF2F5199A72Q34077870-C303C418-1795-4519-9AFA-FE44B286D38CQ34124213-D97FE1F1-CD7C-4B4B-A5F9-346866BBE705Q34142374-ABD804A3-C1B6-4712-8FF4-187429412DF5Q34151538-56642254-A974-4D30-98CE-6F8F808B4709Q34161874-312BF114-1775-4BDB-8C9A-EFE098861675Q34219439-DDABC5DA-76C7-4831-AF53-4706FC2963EFQ34272651-65658A2C-6E76-4A2A-A2C0-E219C9ED8E52Q34281450-F2270AF9-AA1D-4966-B5EF-6FB053C6D207Q34339595-E27AC5AC-5B98-49F1-8944-312FE00AB5E7Q34351746-D67D513A-5838-4F11-993F-D48416B2C38DQ34385492-BD5A9717-D8BC-49E8-A692-A5F19376DA9BQ34411671-D941F748-8E0C-4D05-90BE-4F2C5F56D9B5Q34444944-B02EB307-FC52-4CD0-B794-A0786C08E761Q34455487-84B85BE2-8BE7-4D29-9C30-ACD58AD82900Q34562274-5EAC9D0F-FDA0-4A29-B84E-C56EAB9F02F1Q34563525-DD257013-46E9-4AD7-93BF-9DBB8E6C19B3
P2860
Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Albuminuria and kidney functio ...... and renal outcomes in diabetes
@en
Albuminuria and kidney functio ...... nd renal outcomes in diabetes.
@nl
type
label
Albuminuria and kidney functio ...... and renal outcomes in diabetes
@en
Albuminuria and kidney functio ...... nd renal outcomes in diabetes.
@nl
prefLabel
Albuminuria and kidney functio ...... and renal outcomes in diabetes
@en
Albuminuria and kidney functio ...... nd renal outcomes in diabetes.
@nl
P2093
P2860
P50
P356
P1476
Albuminuria and kidney functio ...... and renal outcomes in diabetes
@en
P2093
ADVANCE Collaborative Group
Anushka Patel
Avinesh Pillai
Bastiaan E de Galan
Bruce Neal
Bryan Williams
Carl-Erik Mogensen
Mark Cooper
Mark Woodward
Neil Poulter
P2860
P304
P356
10.1681/ASN.2008121270
P577
2009-05-14T00:00:00Z